CD103 expression correlated tightly with CD11cHi expression (Fig. S1), permitting use of CD19+CD11cHi FC gates to delineate tumor cells and exclude non-tumor B-cells (n = 10 mult-HCL cases). This evidence concerns the gene CD19 and neoplasm.